DMPI to Begin Trading on NASDAQ Capital Market on July 12, 2016 VANCOUVER, British Columbia and MENLO PARK, Calif., July 11, 2016, DMPI, /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (“DelMar” and the “Company”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, announced today that it has received approval from the Nasdaq Stock Market LLC (“NASDAQ”) for the listing of its common stock on the NASDAQ Capital Market. DelMar’s common stock will beginRead more
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
- Financial Gravity Selects Securities Transfer Corporation as Transfer Agent
- Wayfair Reports 58% Increase in Direct Retail Sales for Peak Five-Day Holiday Shopping Weekend
- Marijuana tech firm Metrc gets $50M with help from Snoop Dogg, Tiger Global
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More